Insys Therapeutics, Inc. (INSY) stock prices updated...
 

Insys Therapeutics, Inc. stock price

Insys Therapeutics, Inc. latest news:


  • 11/16/2017 13:02:24

    UPDATE 2-Billionaire founder of Insys pleads not guilty to opioid bribe scheme

    BOSTON, Nov 16 (Reuters) - The billionaire founder of drugmaker Insys Therapeutics Inc pleaded not guilty on Thursday to charges that he participated in a scheme to bribe doctors to prescribe a fentanyl-based spray to treat pain in cancer patients.

  • 11/16/2017 11:03:37

    UPDATE 1-Billionaire founder of Insys pleads not guilty to opioid bribe scheme

    BOSTON, Nov 16 (Reuters) - The billionaire founder of drugmaker Insys Therapeutics Inc pleaded not guilty to charges that he participated in a scheme to bribe doctors to prescribe a fentanyl-based spray intended for cancer patients.

  • 11/16/2017 04:00:19

    Billionaire founder of Insys to plead not guilty to opioid bribe scheme

    The billionaire founder of Insys Therapeutics Inc (INSY) was expected to appear in federal court in Boston on Thursday to plead not guilty to charges that he participated in a scheme to bribe doctors to prescribe a fentanyl-based cancer pain drug.

  • 10/29/2017 18:06:42

    UPDATE 1-INSYS founder resigns from board after charges in U.S. opioid bribe case

    Oct 29 (Reuters) - The billionaire founder of INSYS Therapeutics Inc John Kapoor, has resigned from the company's board of directors, INSYS said in a statement on Sunday. Kapoor was arrested on Thursday on U.S. charges he participated in a scheme to bribe doctors to prescribe a fentanyl-based cancer pain drug, marking a step by authorities to fight the opioid epidemic.

  • 10/29/2017 17:45:54

    INSYS founder resigns from board after charges in U.S. opioid bribe case

    Oct 29 (Reuters) - The billionaire founder of INSYS Therapeutics Inc John N. Kapoor, has resigned from the company's board of directors, the company said in a statement on Sunday. Kapoor was arrested on Thursday on U.S. charges he participated in a scheme to bribe doctors to prescribe a fentanyl-based cancer pain drug, marking a step by authorities to fight the opioid epidemic.

  • 10/26/2017 20:00:13

    UPDATE 3-Billionaire Insys founder charged in U.S. opioid bribe case

    BOSTON, Oct 26 (Reuters) - The billionaire founder of Insys Therapeutics Inc was arrested on Thursday on U.S. charges he participated in a scheme to bribe doctors to prescribe a fentanyl-based cancer pain drug, marking a step by authorities to fight the opioid epidemic.

  • 10/26/2017 13:56:00

    Founder of US drug company arrested

    Prosecutors charge the former head of Insys Therapeutics in a case related to the US opioid crisis.

  • 10/26/2017 10:11:43

    Insys Therapeutics shares plummet 8% on Justice Dept. charges against founder and six former executives

    Insys Therapeutics Inc. shares plummeted 8% in heavy midday trade Thursday after the company's founder and majority owner was arrested and charged, along with six former executives, with illegally acting to promote the company's opioid medications and fuel the opioid epidemic. Insys founder John Kapoor, Michael Babich, a former CEO and president of the company, and others were charged by the Department of Justice with allegedly bribing doctors and misleading and defrauding health insurers to promote the powerful opioid medication Subsys. "We must hold the industry and its leadership accountable - just as we would the cartels or a street-level drug dealer," said Acting United States Attorney William Weinreb in a statement. Insys shares have plummeted 43% to $6.85 over the last three months, compared with a 3.5% rise in the S&P 500 .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 10/26/2017 10:10:46

    UPDATE 1-Billionaire Insys founder charged in U.S. opioid bribe case

    BOSTON, Oct 26 (Reuters) - The billionaire founder of Insys Therapeutics Inc was arrested on Thursday on U.S. charges that he participated in a scheme with other executives to bribe doctors to prescribe a fentanyl-based cancer pain drug and to defraud insurers.

  • 10/26/2017 09:24:57

    Billionaire Insys founder charged in U.S. opioid bribe case

    BOSTON, Oct 26 (Reuters) - The billionaire founder of Insys Therapeutics Inc has been indicted on U.S. charges that he participated in a scheme with other executives to bribe doctors to prescribe a fentanyl-based drug and defraud insurers.

  • 10/05/2017 10:56:14

    New Jersey is suing Insys over its opioid sales practices

    New Jersey filed a lawsuit against drugmaker Insys Therapeutics Inc. on Thursday alleging that the company engaged in illegal sales practices for the powerful opioid-fentanyl drug Subsys. Insys' actions allegedly "led to the death of at least one New Jersey resident," the lawsuit said, referring to a 32-year-old New Jersey woman who was prescribed Subsys for fibromyalgia. Subsys was approved in 2012 to manage "breakthrough pain in adult cancer patients who are already receiving and who are tolerant to around-the-clock opioid therapy," according to the Food and Drug Administration. Despite this, Insys allegedly pushed "off-label" use of the drug to doctors, according to the complaint. "Knowing full well it was putting lives in peril by pushing for broad based consumption of a highly-specialized and incredibly powerful prescription drug... Insys allegedly forged ahead and did it anyway," said New Jersey Attorney General Christopher Porrino, calling the alleged actions "nothing short of evil." The lawsuit also claims that Insys employees used or developed false records, "including false diagnoses of cancer, breakthrough cancer pain and other afflictions" to ensure the drug would be covered. Insys shares were up 0.3% in midday trade. Shares have plummeted 29% over the last three months, compared with a nearly 5% rise in the S&P 500 .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 09/06/2017 15:48:56

    U.S. senator reveals results of opioid inquiry into Insys

    BOSTON, Sept 6 (Reuters) - Insys Therapeutics Inc sought to manipulate the process to gain insurance payment approval for an opioid cancer pain drug called Subsys even if for inappropriate uses, according to a U.S. Senate report related to the national opioid addiction crisis released on Wednesday.

  • More trends:

    Intec Pharma Ltd.NTEC | Integra LifeSciences Holdings CorporationIART | Integrated Device Technology, Inc.IDTI | Integrated Electrical Services, Inc.IESC | Integrated Silicon Solution, Inc.ISSI | Intel CorporationINTC | Inteliquent, Inc.IQNT | Intellipharmaceutics International Inc.IPCI | Inter Parfums, Inc.IPAR | Interactive Brokers Group, Inc.IBKR |